Changes in mitral annular geometry and dynamics with β-Blockade in patients with degenerative mitral valve disease

18Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Background - Remodeling of the mitral annulus contributes to progression of mitral regurgitation (MR). In patients with moderate-to-severe MR, short-term treatment withα-blockers has been shown to increase left ventricular (LV) end-diastolic and end-systolic volume, and this could deleteriously increase mitral valve annular dimensions. The objective of this study was to quantify the effects of a short duration of β-blocker treatment on mitral annular dimensions and dynamics in patients with MR due to primary degenerative valve disease. Methods and Results-Twenty-five patients with moderate-to-severe degenerative MR and normal LV systolic function were studied in a double-blind crossover experiment using a β1-selective adrenergic blocker and placebo administered for 14±3 days. Cardiac MRI images were acquired after each treatment period to quantify mitral annular dimensions. At end diastole, there was no change in annular area (1659±331 versus 1632±299 mm 2; P

Cite

CITATION STYLE

APA

Ennis, D. B., Rudd-Barnard, G. R., Fonseca, C. G., Young, A. A., Cowan, B. R., & Stewart, R. A. H. (2010). Changes in mitral annular geometry and dynamics with β-Blockade in patients with degenerative mitral valve disease. Circulation: Cardiovascular Imaging, 3(6), 687–693. https://doi.org/10.1161/CIRCIMAGING.110.959171

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free